Cleared Traditional

K223504 - Ceribell Status Epilepticus Monitor (FDA 510(k) Clearance)

May 2023
Decision
182d
Days
Class 2
Risk

K223504 is an FDA 510(k) clearance for the Ceribell Status Epilepticus Monitor. This device is classified as a Automatic Event Detection Software For Full-montage Electroencephalograph (Class II - Special Controls, product code OMB).

Submitted by Ceribell, Inc. (Sunnyvale, US). The FDA issued a Cleared decision on May 23, 2023, 182 days after receiving the submission on November 22, 2022.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.1400. Automatically Mark Or Identify Electroencephalograph Waveforms For Spikes, Electrographic Seizures, Seizure-like Events In Order To Aid In Identification Of Such Events And Help Review And Annotation Of Prolonged Eeg Traces; All Output Subject To Verification By Qualified User.

Submission Details

510(k) Number K223504 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 22, 2022
Decision Date May 23, 2023
Days to Decision 182 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code OMB - Automatic Event Detection Software For Full-montage Electroencephalograph
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Automatically Mark Or Identify Electroencephalograph Waveforms For Spikes, Electrographic Seizures, Seizure-like Events In Order To Aid In Identification Of Such Events And Help Review And Annotation Of Prolonged Eeg Traces; All Output Subject To Verification By Qualified User